Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/03/25 | Current report |
|
 |
21 | |
| 12/03/25 | Current report |
|
|
8 | |
| 11/10/25 | Quarterly report [Sections 13 or 15(d)] |
|
|
54 | |
| 11/10/25 | Current report |
|
|
8 | |
| 10/30/25 | Statement of Beneficial Ownership by Certain Investors |
|
4 | ||
| 09/23/25 | Notice of Effectiveness |
|
1 | ||
| 09/10/25 | Registration statement under Securities Act of 1933 |
|
|
99 | |
| 08/11/25 | Quarterly report [Sections 13 or 15(d)] |
|
|
57 | |
| 08/11/25 | Current report |
|
|
8 | |
| 07/29/25 | Statement of Beneficial Ownership by Certain Investors |
|
4 |